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500Zinc ﬁnger protein 191 deﬁciency attenuates
vascular smooth muscle cell proliferation,
migration, and intimal hyperplasia after
endovascular arterial injury
Lei Lv, MD, Jiwei Zhang, MD, Peng Wang, MD, Qiurong Meng, MD, Wei Liang, MD, PhD,
and Lan Zhang, MD, PhD, Shanghai, China
Objective: Restenosis engenders surgical vascular intervention failure. Zinc ﬁnger protein 191 (ZFP191) is a novel
member of the SCAN domain family of Krüppel-like zinc ﬁnger transcription factors. Previous work reveals that ZFP191
is a pleiotropic factor that plays important roles in hematopoiesis, brain development, and tumor growth. Here, we
sought to determine whether intimal hyperplasia was affected by the activity of ZFP191 and to investigate the molecular
mechanisms that may underpin the process.
Methods: Intimal hyperplasia was induced by guidewire injury in mouse femoral arteries. The arteries were harvested for
morphometric assessment and determination of ZFP191 expression. Next, ZFP191 knockdown in cultured mouse aortic
vascular smooth muscle cells (VSMCs) was achieved by lentiviral transduction of short-hairpin RNA. MTT (3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) assay, [3H]thymidine incorporation assay, scratch assay, and
transwell migration assay were used to evaluate the effects of ZFP191 knockdown on VSMC growth and migration. In
addition, b-catenin, c-myc, cyclin D1, matrix metalloproteinase (MMP) 9, MMP2, andMMP7 were measured by Western
blotting in the absence of ZFP191 in vitro and in vivo. Zymography was used to evaluate MMP activity in cell culture-
conditioned media. Lastly, artery injury was performed in wild-type (WT) and heterozygous ZFP191 knockout (KO)
mice, and morphometric analysis of the arteries was determined.
Results: Guidewire injury was associated with development of intimal hyperplasia, and ZFP191 expression was enhanced by
51% in the injured arteries. Cultured primary VSMCs transfected with lentiviral shZFP191 displayed reduced proliferation
and migration compared with controls. Mechanically, ZFP191 knockdown potently decreased the level of b-catenin and its
downstreamtargets c-mycandcyclinD1.ZFP191knockdowndownregulated the expressionofMMP9,MMP2, andMMP7,
and zymography conﬁrmed that ZFP191 knockdown reduced the activity of MMPs. Consistent with the in vitro data,
elevated expression of b-catenin, c-myc, cyclin D1, MMP9,MMP2, andMMP7 accompanied upregulation of ZFP191 after
injury in the femoral arteries ofmice, and these levelswere downregulated inZFP191KOvessels. Finally, intimal hyperplasia
was greatlyblocked inheterozygousZFP191KOmice comparedwithWTmice (intima/media ratio,0.124vs0.412;P< .05).
Conclusions: ZFP191 played an essential role in aggressive proliferation and migration of VSMCs, which in turn facili-
tated intimal hyperplasia. Our ﬁndings offer the ﬁrst genetic evidence of ZFP191 as a potential therapeutic target to
prevent restenosis. (J Vasc Surg 2014;59:500-9.)
Clinical Relevance: Open reconstruction and angioplasty serve as two major treatments for peripheral arterial occlusive
disease. However, these procedures result in high rates of restenosis, which is still a critical problem today. The histology
of the stenotic lesion is primarily intimal hyperplasia. Aggressive vascular smooth muscle cell (VSMC) proliferation and
migration has been considered for a long time to be the Achilles’ heel of intimal hyperplasia. In this regard, inhibition of
VSMC proliferation and migration has been considered as a key step to control the pathophysiologic process in restenosis.
This study suggests that ZFP191 increases VSMC proliferation and migration and may do so through activating the
Wnt/b-catenin signaling pathway and matrix metalloproteinases. We suggest that these pioneering experimental and
preclinical data can promote creating new therapeutic strategies by inhibiting ZFP191 to prevent restenosis.the Department of Vascular Surgery, Renji Hospital, School of
edicine, Shanghai Jiaotong University.
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://dx.doi.org/10.1016/j.jvs.2013.03.049Restenosis has remained a major drawback of surgical
vascular interventions, particularly angioplasty. Intimal
hyperplasia, deﬁned as abnormal growth of the intimal layer
of blood vessels, is considered a critical event in the develop-
ment of restenosis and atherosclerosis. After vascular injury,
vascular smoothmuscle cells (VSMCs) acquire a newpheno-
type,migratemore to the site of injury, and then showprolif-
eration and adhesion at the intimal layer.1-4 Although the
exact mechanism of these complicated events is not fully
understood, inhibition of the VSMC proliferation and
migration that follows the vascular injury is considered
a general therapeutic strategy for restenosis.
JOURNAL OF VASCULAR SURGERY
Volume 59, Number 2 Lv et al 501A signiﬁcant number of transcription factors use
a conserved zinc ﬁnger domain to bind their target
DNAs. Zinc ﬁnger factors participate in a variety of cellular
activities, including development and differentiation, and
play a role in human disease such as neurologic disease
and cancers. Zinc ﬁnger protein 191 (ZFP191), also
known as ZNF191 and ZNF24, is a putative transcription
factor that belongs to the Krüppel-like zinc ﬁnger gene
family. It contains four Cys2/His2 zinc ﬁngers in its
C-terminus, and one SCAN box element (also known as
LeR domain for leucine-rich) in its N-terminus.5,6
ZFP191 is considered as a pleiotropic factor that has
a role in hematopoiesis, brain development, and tumor
growth. For example, the gene expressing ZFP191 is local-
ized to chromosome 18q12.1, a region frequently deleted
in colorectal carcinomas, suggesting a possible tumor-
suppressor role for ZFP191.7 However, ZFP191 is signiﬁ-
cantly overexpressed in human hepatocellular carcinoma
specimens and is associated with the growth of human
hepatocellular carcinoma cells, indicating a role in the
positive regulation of tumor growth.8 Inactivation of
ZFP191 is embryonic lethal, also indicating that the gene
is required for development.9
ZFP191 can speciﬁcally bind to the TCAT repeats
(HUMTH01) in the ﬁrst intron of the human tyrosine
hydroxylase (TH) gene. HUMTH01 may regulate tran-
scription of the TH gene, which encodes the rate-
limiting enzyme in the synthesis of catecholamines.10
Disturbances of catecholaminergic neurotransmission have
been implicated in cardiovascular diseases.11
The presence of ZFP191 expression in multiple tissues
and at multiple stages of development implies that the gene
may have important biologic functions. Nevertheless, there
has been no link between ZFP191 and restenosis and no
direct evidence of the role of ZFP191 in the proliferation
and migration of VSMCs.
The present study tested the hypothesis that ZFP191
participates in VSMC proliferation and migration and is
involved in neointima formation. The inhibiting effects of
ZFP191 knockdown on VSMC proliferation and migration
in vitro were identiﬁed for the ﬁrst time. We also tried to
clarify its molecular mechanism. Furthermore, we applied
a femoral artery injury model that resembled human reste-
nosis after angioplasty to heterozygous ZFP191 knockout
(KO) mice and showed that the ZFP191 deﬁciency pre-
vented restenosis.
METHODS
All animal experiments performed in this study were in
accordance with and were approved by the Institutional
Ethical Guidelines on Animal Care, Renji Hospital, School
of Medicine, Shanghai Jiaotong University.
Isolation and culture of VSMCs. Aortas were har-
vested from 9- to 12-week-old C57BL/6J male mice.
Adventitia was dissected from the media, which was
cultured to yield VSMCs, whose phenotype was conﬁrmed
by typical morphology and positive immunostaining with
smooth muscle a-actin antibody. Seven separate isolates ofVSMCs were obtained and characterized, derived from
a pool of aortas from three individual mice for each
genotype. VSMCs were grown in Dulbecco’s modiﬁed
Eagle’s medium (DMEM) containing 10% fetal bovine
serum (FBS). Cells between passages two and ﬁve were
used for experiments. Unless otherwise indicated, cells
reaching 80% to 90% of conﬂuence were starved and
synchronized in DMEM at 37C for 24 hours and then
subjected to further analysis.
Animals. Heterozygote breeders for the ZFP191 KO
mouse strain were purchased from Shanghai Nanfang
Research Center for Biomodel Organism. Heterozygous
ZFP191þ/ mice are normal and fertile; however,
homozygous ZFP191/ mice are lethal. ZFP191þ/
were backcrossed >10 times to the C57BL/6J genetic
background. The generation of the ZFP191þ/ mouse
has been described in details elsewhere.9 One genomic
clone, w18 kb, comprising the complete ZFP191 gene
(GenBank accession number AY052495) was isolated from
a lambda 129/SvJ genomic library using a human ZFP191
complementary DNA probe. The ZFP191 gene is
composed of four exons, and the entire open reading frame
for ZFP191 resides in exons 2 to 4 in the mouse genome.
A replacement-type vector containing 10.5-kb isogenic
DNA, which allowed the deletion of exon 2 to 4, was
constructed and used to generate heterozygous ZFP191
KO mice (ZFP191þ/). C57BL/6J mice matched for age
and gender were used as wild-type (WT) controls. Mice
were maintained under standard conditions on a 12-hour
light/dark cycle with free access to water and food.
Lentiviral vector construction and RNA inter-
ference. A third generation of self-inactivating lentivirus
vector containing a cytomegalovirus-driven enhanced green
ﬂuorescent protein reporter and a U6 promoter upstream
of cloning restriction sites (HpaI and XhoI) to allow the
introduction of oligonucleotides encoding short-hairpin
RNAs (shRNAs) was purchased from Shanghai Gene-
Pharma Co, Ltd, Shanghai, China. We constructed three
shZFP191 lentiviruses targetingmurine ZFP191messenger
RNA starting at 316, 973, and 1057, respectively. Lentiviral
transduction efﬁciency in VSMCs was determined by
immunoﬂuorescence. Efﬁciency of endogenous ZFP191
knockdown by shZFP191 encoding virus was determined
using semiquantitative real-time reverse transcription poly-
merase chain reaction. The most efﬁcient one (ZFP191-
mus-973) in other experiments was selected for this study
(the efﬁciency of lentiviral vector transduction in VSMCs
was 80%). The primer sequences were forward: 50-TGC
CGT ATG GAT GTG TTG AAT GTT TCA AGA GAA
CATTCAACACATCCATACGGCTTTTTTC-30; and
reverse: 50-TCG AGA AAA AAG CCG TAT GGA TGT
GTT GAA TGT TCT CTT GAA ACA TTC AAC ACA
TCC ATA CGG CA-30.
Viral titers were determined by standard procedures,
and lentivirus transduction was performed as described
previously.12,13
Cell proliferation assays. Cell proliferation was de-
termined by two methods. VSMCs (5  103 cells/well)
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dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide)
reagent was added to each well, and absorbance of the
formazan from each sample was measured at a test wave-
length (570 nm) at indicated time points. VSMCs plated in
12-well plates (4  104 cells/well) were incubated in
complete medium containing tritiated [3H]thymidine
(1 mCi/mL). Tritiated [3H]thymidine incorporated into
trichloroacetic acid-precipitated DNA was measured with a
liquid scintillation counter. Each experiment was repeated
six times.
Cell migration assay. Cell migration was determined
by two methods. VSMCs were plated at an initial density
of 1  105 cells/mL to form a monolayer. Then, cells
were wounded by scraping with a pipette tip to make
a gap in the cell monolayer. The images of cell migration
were observed immediately after scratching and at 24 hours
and photographed at ﬁve marked locations on each dish
using a phase-contrast microscope. The number of
migrated cells was counted and averaged. A 24-well
transwell plate that contained polycarbonate 8-mm pore
membrane ﬁlters was used. VSMCs (1  105 cells) were
seeded in the upper wells in 200-mL serum-free DMEM
containing 1% FBS, whereas the lower wells were ﬁlled
with 600-mL DMEM containing 10% FBS.
After 12 hours of incubation, all nonmigrant cells were
removed from the upper face of the transwell membrane
with a cotton swab, and migrant cells were ﬁxed and
stained with 0.1% hexamethylpararosaniline chloride in
4% paraformaldehyde. Migration cells were quantiﬁed by
counting the number of stained cells from ﬁve randomly
chosen ﬁelds under a phase-contrast microscope and pho-
tographed. All experiments were repeated six times.
Western blot analysis. Protein was extracted from
the femoral arteries (after careful removal of adventitial tissue)
of each group (ﬁvemice were used in each group) or cultured
VSMCs. Expression of ZFP191, b-catenin, c-myc, cyclin D1,
matrix metalloproteinase (MMP) 9, MMP2, and MMP7
was analyzed by Western blotting. The antibodies against
b-catenin, c-myc, cyclin D1, MMP9, MMP2, and MMP7
were purchased fromAbcam(Cambridge,UnitedKingdom),
the antibody against ZFP191 was purchased from Aviva
Systems Biology (San Diego, Calif), and the antibody against
ZFP191 was purchased from Santa Cruz Biotechnology, Inc
(Santa Cruz, Calif). The expression level of tubulin served as
an internal control for protein loading. Three independent
experiments were performed.
Zymography analysis. Enzyme activities of MMPs
were assessed by zymography using gelatin (for MMP2
and MMP9) or casein-impregnated gels (for MMP7),
according to the manufacturer’s instructions (GENMED
Scientiﬁcs, Shanghai, China). Equal amounts of condi-
tioned media from identical numbers of cells were loaded
onto 10% sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis gels containing 0.1 g/mL gelatin or 1 mg/mL
casein, and electrophoretically separated at 10 mA for 3
hours under nonreducing conditions. The subtypes of
MMPs were identiﬁed by the use of molecular weightstandards and by running samples of puriﬁed MMP2,
MMP7, and MMP9 enzymes (Calbiochem, San Diego,
Calif). The gel was stained with 0.2% Coomassie brilliant
blue and photographed on a light box. Areas of enzymatic
degradation were quantiﬁed by densitometry, and all
experiments were performed in triplicate.
Arterial injury models. Each mouse (9 and 12 weeks
old) was anesthetized by an intraperitoneal injection of
pentobarbital (50 mg/kg) diluted in 0.9% sodium chloride
solution (eight per group). Guidewire injury of the femoral
artery was performed by three passages of a 0.014-inch
Radius X-TRa Support PTCA Guidewire (Radius Medical
Technologies, Maynard, Mass). Brieﬂy, the exposed
muscular branch artery was dilated by the topical applica-
tion of one drop of 1% lidocaine hydrochloride. Transverse
arteriotomy was performed in the muscular branch, and
a microsurgery forceps was used to extend the arteriotomy
through which the wire was carefully inserted into the
femoral artery for >5 mm toward the iliac artery. Control
sham-operated arteries (the opposite hind limb of the same
mouse) underwent dissection and temporary clamping
without passage of the wire. A dissecting microscope was
used for the procedure. After removal of the wire, the
arteriotomy site was ligated.
None of the mice exhibited signs of ischemia in their
hind limbs, and all mice had full use of the limb immediately
after surgery. Because ZFP191 expression was induced and
peaked in the femoral artery at day 7 after injury (data not
shown), femoral arteries were perfusion-ﬁxed, harvested,
and embedded in parafﬁn 7 days after surgery. Femoral
arteries for Western blot analysis were rapidly removed,
rinsed with cold saline solution to remove blood, cleaned
of extraneous material, and frozen in liquid nitrogen.
Morphometric analysis. Femoral arteries harvested at
7 days after wire injury were examined histologically for
evidence of neointimal hyperplasia using routine hematox-
ylin and eosin staining. Digital images were collected with
light microscopy using an Olympus BHT microscope
(Melville, NY) with 100 objective. Six evenly spaced
sections through each femoral artery were morphometri-
cally analyzed. Intimal (I) and medial (M) areas were
measured using ImageJ software (National Institutes of
Health, Bethesda, Md).
Immunohistochemical staining. For the immunohis-
tochemistry of ZFP191, a universal immunoenzyme poly-
mer method was used for immunostaining. Sections were
cut from formalin-ﬁxed, parafﬁn-embedded tissue blocks,
mounted on polylysine-coated slides, dewaxed in xylene,
and rehydrated through a graded ethanol series. After
deparafﬁnization, antigen retrieval treatment was per-
formed at 121C for 15 minutes in 10-mM sodium citrate
buffer (pH 6.0), and samples were then treated with 3%
hydrogen peroxide in methanol solution for 20 minutes
to quench endogenous peroxidase activity. To block in-
trinsic avidin-biotin binding, the tissue slides were treated
with avidin-biotin blocking kit reagents (Vectastain Elite
ABC kit, Vector Laboratories, Burlingame, Calif) for 15
minutes. Anti-ZFP191 antibodies were used as the primary
Fig 1. Zinc ﬁnger protein 191 (ZFP191) is activated in guidewire-injured mouse femoral arteries. Artery proteins were
extracted from sham and guidewire-injured mouse femoral arteries on day 7. Samples were probed with anti-ZFP191
polyclonal antibody. Tubulin served as an internal control. A, Representative Western blots for heterozygous ZPD191
knockout mice (KO) and wild-type (WT) mice. B, Bar graph shows relative densitometric values of the Western blots.
Values are expressed as mean 6 standard deviation from three independent experiments. *P < .05 vs sham. xP < .05 vs
WT. Representative photomicrographs (original magniﬁcation, 200) show immunohistochemistry analysis of
ZFP191 in (C) uninjured femoral arteries and at (D) 7 days after guidewire injury. The brown staining represents
cellular ZFP191 expression. Results shown are representative of three independent experiments.
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3-30 diaminobenzidine tetrahydrochloride detection system
(DakoCytomation, Glostrup, Denmark). All experiments
were performed in triplicate.
Data analysis. Data are presented as mean 6 standard
deviation. Differences between the two groups were
assessed by Student t-tests. Data among more than two
groups were assessed by analysis of variance, followed bythe Bonferroni multiple comparisons test. P < .05 was
considered statistically signiﬁcant.
RESULTS
Elevated ZFP191 accompanies intimal hyperplasia
after vascular injury. ZFP191 is known to be ubiqui-
tously expressed.14 Here, we determined the expression
of ZFP191 in mouse uninjured and guidewire-injured
Fig 3. Silencing zinc ﬁnger protein 191 (ZFP191) inhibits vascular smooth muscle cell (VSMC) growth. VSMCs were
ﬁrst transfected with control (CON, VSMCs uninfected with lentivirus) or short-hairpin ZFP191 lentiviruses. Cell
proliferation was assessed by the (A) MTT (3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) assay (B)
and [3H]-thymidine incorporation analyses. Values are expressed as mean 6 standard deviation (range bars) from six
independent experiments. *P < .05 vs CON/NC. KD, VSMCs infected with lentivirus carrying short-hairpin ZFP191;
NC, VSMCs infected with control lentivirus.
Fig 2. Transduction of lentiviral short-hairpin zinc ﬁnger protein 191 (ZFP191) vector suppresses the ZFP191 protein
level in vascular smooth muscle cells. The subconﬂuent cells were infected with control (empty lentivirus vector) or
short-hairpin ZFP191 lentiviruses. Cells were collected and lysed for analysis at 7 days after infection. Tubulin served as
an internal control. A, Representative Western blots. B, Bar graph shows relative mean densitometric values of Western
blots, with error bars indicating the standard deviation. Results shown are representative of three independent
experiments. *P < .05 vs CON/NC. CON, Control (vascular smooth muscle cells uninfected with lentivirus); KD,
vascular smooth muscle cells infected with lentivirus carrying shZFP191; NC, vascular smooth muscle cells infected
with control lentivirus.
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intimal hyperplasia developed in guidewire-injured mouse
femoral arteries after injury. Western blot analysis showed
a signiﬁcant increase of ZFP191 protein level in injured
compared with sham-operated arteries 7 days after injury
(Fig 1, A and B). Similarly, immunohistochemical analysis
demonstrated a clear increase of ZFP191 expression in
wire-injured arteries compared with sham (Fig 1, C). This
ﬁnding implied that ZFP191 might be involved in the
development of intimal hyperplasia lesions after guidewire
injury in mice.
Knockdown of ZFP191 in VSMCs inhibits cell
proliferation. To test the hypothesis that ZFP191 was
a regulator of VSMC growth, we used RNA interference
to knock down ZFP191 expression and determined the
effect on VSMC proliferation. After transfection of
VSMCs with shZFP191 lentivirus, we observed effective
knockdown of ZFP191 at the protein level (Fig 2, A
and B). ZFP191 knockdown by lentivirus-mediated
transfer caused a dramatic reduction in the proliferationof VSMCs by means of MTT assay (Fig 3, A). A similar
proliferation status was observed after use of the [3H]
thymidine incorporation assay in VSMCs (Fig 3, B),
which indeed echoes with its inhibitory effect on VSMC
proliferation.
ZFP191 knockdown in VSMCs retards migratory
capacity. Because cell migration is also essential for reste-
nosis after angioplasty, we then examined whether knock-
down of ZFP191 had negative effects on cell migration.
Interestingly, ZFP191 knockdown by lentivirus-mediated
transfer led to a marked decrease in migratory capacity by
the method of scratch assay (Fig 4, A and B). Consistently,
knockdown of ZFP191 signiﬁcantly repressed VSMC
migration when transwell migration assay was performed
(Fig 4, C and D).
Inhibition of ZFP191 inactivates Wnt/b-catenin
signaling. ZFP191 was reported to be a modulator of
the Wnt/b-catenin signaling pathway.8 Therefore, we
evaluated the role of ZFP191 modulation on the
Wnt/b-catenin pathway. The protein expression of
Fig 4. Silencing zinc ﬁnger protein 191 (ZFP191) suppresses vascular smooth muscle cell (VSMC) migration. VSMCs
were ﬁrst transfected with control (CON, VSMCs uninfected with lentivirus) or short-hairpin ZFP191 lentiviruses.
The conﬂuent VSMC monolayers were wounded by scraping. A, Cell migration to the wound surface was monitored
from 0 to 24 hours. B, The number of migrated cells was counted and averaged. C, Migration assay was performed
with transwell culture chambers (original magniﬁcation, 200). D, Five different areas of migrated cells were counted.
Values are expressed as mean 6 standard deviation (error bars) from six independent experiments. *P < .05 vs CON/
NC. KD, VSMCs infected with lentivirus carrying short-hairpin ZFP191; NC, VSMCs infected with control lentivirus.
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Fig 5. Effect of lentivirus-mediated short-hairpin zinc ﬁnger protein 191 (shZFP191) on related proteins of ZFP191
in vascular smooth muscle cells (VSMCs). VSMCs were ﬁrst transfected with control (CON, VSMCs uninfected with
lentivirus) or shZFP191 lentiviruses. The cells were lysed, and proteins from cell lysates were resolved by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis, transferred to a polyvinylidene ﬂuoride membrane, and blotted with
(A) anti-b-catenin, anti-c-myc, anti-cyclin D1, and (C) anti-matrix metalloproteinase (MMP) 9, anti-MMP2, anti-
MMP7, or anti-tubulin antibodies to analyze protein expression. B and D, Bands were quantiﬁed by densitometric
analysis, and the results are shown as relative density compared with control. Values are expressed as mean 6 standard
deviation from three independent experiments; *P < .05 vs CON/NC. KD, VSMCs infected with lentivirus carrying
shZFP191; NC, VSMCs infected with control lentivirus.
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silenced for ZFP191. The protein level of b-catenin was
lower in VSMCs silenced for ZFP191 than in that of the
control cells (Fig 5, A and B). Furthermore, because
c-myc and cyclin D1 have previously been identiﬁed as
downstream targets of ZFP191,15 we also examined these
two proteins in VSMCs silenced for ZFP191. As ex-
pected, the expression of c-myc and cyclin D1 signiﬁ-
cantly decreased in VSMCs transfected with shZFP191
lentiviruses compared with the control cells. Moreover, to
determine directly whether the in vitro effects of ZFP191
deﬁciency were relevant to in vivo effects, we also tested
the expression of b-catenin, c-myc, and cyclin D1 in
femoral arteries of mice. Vascular injury resulted in
dramatically increased expression of these proteins. There
was progressive downregulation of ZFP191 expression in
heterozygous ZFP191 KO mice, and these levels were
signiﬁcantly lower in heterozygous ZFP191 KO mice
compared with WT mice (Fig 1, A; Fig 6, A and B).
Inhibition of ZFP191 downregulates MMP
expression. Next, we addressed possible molecular mech-
anisms underlying inhibited migratory capacity in VSMCs
after transfection with shZFP191 lentiviruses. MMPshave been shown to respond to Wnt/b-catenin pathway
stimulation in other cell models,16-18 and MMPs play
a key role in the invasion through extracellular matrix. Our
data showed that diminishing ZFP191 expression caused
a dramatic degradation of the protein abundance of
MMP9, MMP2, and MMP7 (Fig 5, C and D). Moreover,
enzymatic activity of MMP2, MMP7, and MMP9 was also
reduced in shZFP191-transfected VSMCs using zymog-
raphy analysis (Fig 7, A and B). These ﬁndings might
explain why deletion of ZFP191 negatively affected VSMC
migration. Furthermore, the expression of MMP9,
MMP2, and MMP7 was substantially enhanced in mouse
femoral arteries with endothelial damage, consistent with
upregulation of ZFP191. The extent of these levels was
signiﬁcantly decreased in femoral arteries from heterozy-
gous ZFP191 KO mice compared with WT mice (Fig 6, C
and D).
ZFP191 deﬁciency attenuates postinjury intimal
hyperplasia formation in the vasculature. A guidewire
was used to injure the femoral artery of WT or heterozy-
gous ZFP191 KO mice matched for age, gender, and
strain. Histologic examination revealed that the intimal
hyperplasia was markedly decreased in heterozygous
Fig 6. Alterations of related proteins of zinc ﬁnger protein 191 (ZFP191) in uninjured or injured femoral arteries from
heterozygous ZFP191 knockout (KO) mice compared with wild-type (WT) mice. The samples were sonicated and
vortexed at 10,000g for 30 minutes at 4C. Equivalent amounts of total protein were resolved by sodium dodecyl
sulfate polyacrylamide gel electrophoresis, transferred to a polyvinylidene ﬂuoride membrane, and blotted with anti-
b-catenin, anti-c-myc, anti-cyclin D1, anti-matrix metalloproteinase (MMP) 9, anti-MMP2, anti-MMP7, or anti-
tubulin antibodies to analyze protein expression. Representative blots were shown (A and C). Bands were quantiﬁed by
densitometric analysis, and the results were shown as relative density compared with control (B and D). Values are
expressed as mean 6 standard deviation from three independent experiments. *P < .05 compared with sham; xP < .05
compared with WT.
Fig 7. Zinc ﬁnger protein 191 (ZFP191) knockdown reduced the secretion and activation of matrix metalloproteinase
(MMP) 9, MMP2, and MMP7. Vascular smooth muscle cells (VSMCs) were cultured at a concentration of 4  104
cells/mL on 12-well plates. The conditioned medium was prepared and used for zymography. Representative
zymography gels are shown for (A) MMP9, MMP2, and MMP7. B, Bar graphs show relative densitometric values of
zymography. Results are mean values representative of three independent experiments with the standard deviation
(error bars). *P < .05 vs CON/NC. CON, Control; VSMCs uninfected with lentivirus; KD, VSMCs infected with
lentivirus carrying shZFP191; NC, VSMCs infected with control lentivirus.
JOURNAL OF VASCULAR SURGERY
Volume 59, Number 2 Lv et al 507ZFP191 KO mice compared with WT mice (Fig 8, A). The
ratio of I/M was more than threefold greater in the WT
mice than in the heterozygous KO mice (Fig 8, B).
DISCUSSION
The major ﬁnding in this report is the remarkable effect
that ZFP191 has in the development of intimal hyperplasia
after arterial injury. Two key and novel observations arepresented. First, genetic deﬁciency of ZFP191 in mice
results in almost complete inhibition of restenosis after
endothelial denudation. Second, ZFP191 exerts important
effects on the proliferation and migration of VSMCs,
which may be due to regulation of the Wnt/b-catenin
pathway and effects on their downstream MMP targets.
ZFP191 messenger RNA is widely expressed during
embryonic development and in adult tissues, suggesting
Fig 8. Lesion formation in wild-type (WT) and heterozygous zinc ﬁnger protein 191 (ZFP191) knockout (KO) mice
after injury of the femoral artery. Wire-mediated vascular injury was produced in WT (n ¼ 8) and heterozygous
ZFP191 KO (n ¼ 8) mice. The femoral arteries were excised at 7 days after injury. A, Representative photomicrographs
show sample sections that were stained with hematoxylin and eosin, and intimal hyperplasia formation was evaluated
(original magniﬁcation, 100). B, Bar graphs showed the intima (I)/media (M) ratio quantiﬁed by Image-Pro Plus 6.0
software (Media Cybernetics, Inc, Rockville, Md). Values represent means 6 standard deviation of 10-12 independent
experiments. *P < .05 vs sham.
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processes.14 Examination of the ZFP191/ mouse
demonstrated that this protein is indispensable for early
embryonic development, and ZFP191/ mice died
before embryonic day 7.5.9 Recently, ZFP191 was found
to be required for the myelinating function of differenti-
ated oligodendrocytes.19 ZFP191 was ﬁrst noticed for its
capacity to bind to a tandem repeat TCAT sequence in
the ﬁrst intron of human tyrosine hydroxylase (TH) and
to negatively regulate its transcription.10 Further study sug-
gested that the minimal repeat number of the TCAT motifs
is three for ZFP191 binding, and that any point mutant in
the TCAT motif can destroy this interaction.20 As a widely
expressed transcriptional factor, ZFP191 may be involved
in additional physiologic and pathologic processes. The
observation in our study that ZFP191 expression increased
in the neointima formed after endothelial denudation in
mice gave us a hint of the possible involvement in the
response of VSMC to injury. The lack of neointimal hyper-
plasia observed in heterozygous ZFP191 KO mice is, to
the best of our knowledge, the ﬁrst evidence of the actions
of ZFP191 on vascular remodeling.
In our current study, ZFP191 knockdown resulted in
reduced VSMC proliferation. To further explore the
molecular mechanism by which ZFP191 knockdown
affected VSMC proliferation, we examined a possible link
to the Wnt/b-catenin pathway. The Wnt family of 19
secreted glycoproteins controls a variety of developmental
processes, including cell fate speciﬁcation, proliferation,
polarity, and migration. Consequently, misregulation of
Wnt signalling during embryonic development caused
developmental defects, whereas defective Wnt signalling
in adult tissue results in the development of various
diseases.21 The involvement of the Wnt signaling cascadein cancer is supported by evidence.22,23 Numerous studies
have revealed that b-catenin is upregulated in human
cancers and correlates with poor clinical prognosis.23,24
The most studied pathway mutations in cancer are the
inherited and sporadic mutations in the tumor suppressor
adenomatous polyposis coli (APC) and b-catenin. Because
APC is part of the degradation scaffold for b-catenin, muta-
tions of APC can result in reduced degradation and
increased nuclear accumulation of b-catenin, leading to
activation of target genes such as the oncogenes cyclin
D1 and c-myc.15 Liu et al8 recently reported that
ZFP191 can directly bind to the CTNNB1 promoter and
activate the expression of b-catenin and its downstream
target genes, such as cyclin D1, in hepatoma cell lines. In
aggregate, our present data suggested that ZFP191 knock-
down in VSMCs inhibited cell proliferation by suppressing
b-catenin and its downstream molecules c-myc and cyclin
D1, indicating that the Wnt/b-catenin pathway, at least
in part, played a role in ZFP191-mediated cell proliferation
of VSMCs. This ﬁnding was also supported at a mechanistic
level in vivo in our present study.
In addition to effects of ZFP191 silencing on VSMC
proliferation, a key feature of our study was the identiﬁca-
tion of ZFP191 as a novel regulator of cell migration in
VSMCs. Our data showed that ZFP191 silencing in
VSMCs retarded migratory capacity by downregulating
MMPs. As reported, canonical (b-catenin) Wnt signaling
was important for endothelial cell function in angiogenesis
and Lef1, as a key downstream effector for this pathway in
endothelial cells, speciﬁcally regulated MMP2 expression
in these cells and promoted cell invasion.16
Villar et al17 observed increased expression of the Wnt
target gene product MMP7 that was thought to play an
important role in pulmonary ﬁbrosis. Tamamura et al18
JOURNAL OF VASCULAR SURGERY
Volume 59, Number 2 Lv et al 509demonstrated that target genes of the canonical b-catenin
pathway include MMP2, MMP3, MMP7, and MMP9. It
was interesting to observe that ZFP191 silencing downre-
gulated MMPs (MMP2, MMP7, and MMP9) and reduced
the activity of MMPs. In addition, our in vivo evidence also
showed that the expression of MMPs was dramatically
enhanced, consistent with upregulation of ZFP191 in
mouse femoral arteries after wire injury. The expression
of these levels was signiﬁcantly decreased in femoral arteries
from ZFP191 KO mice compared with WT mice. It is
possible that ZFP191 can regulate the Wnt/b-catenin
pathway in VSMCs, which subsequently activate its target
MMP genes to modulate cell migration, although the
role for MMPs in VSMC migration regulated by ZFP191
requires further conﬁrmation.
CONCLUSIONS
Although it remains to be clariﬁed whether other medi-
ating signals may also contribute to the inhibitory effect of
ZFP191 deﬁciency on VSMC proliferation and migration,
taken together, our results provide new insights into the
molecular mechanisms underlying restenosis. Results
from our in vitro and in vivo study suggest that the
ZFP191 protein serves as a potential therapeutic candidate
for preventing or treating restenosis.
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